Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels-Reference-Cited by-同舟云学术

Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels

Published:2013-08 Issue:2 Volume:148 Page:209-218
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Teixeira Bruna,Bittencourt Vera Carolina B.,Ferreira Thais B.,Kasahara Taissa M.,Barros Priscila O.,Alvarenga Regina,Hygino Joana,Andrade Regis M.,Andrade Arnaldo F.,Bento Cleonice A.M.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Multiple sclerosis and allied demyelinative diseases;Adams,1989

2. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on evaluation of experimental trials of therapy in multiple sclerosis;Schumacher;Ann. N. Y. Acad. Sci.,1965

3. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?;Lovett-Racke;Biochem. Biophys. Acta,1812

4. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation;Langrish;J. Exp. Med.,2005

5. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis;Komiyama;J. Immunol.,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrinolysis associated proteins and lipopolysaccharide bioactivity in plasma and cerebrospinal fluid in multiple sclerosis;Journal of Neuroimmunology;2024-10

2. Perivascular B cells link intestinal angiogenesis to immunity and to the gut-brain axis during neuroinflammation;Journal of Autoimmunity;2024-09

3. Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation;Neurologic Clinics;2024-02

4. Animal model of multiple sclerosis: Experimental autoimmune encephalomyelitis;Methods in Cell Biology;2024

5. Intestinal Barrier Function and Neurodegenerative Disease;CNS & Neurological Disorders - Drug Targets;2023-11-24